{"cik":"0001604464","ticker":"ATRA","name":"Atara Biotherapeutics, Inc.","sic_code":null,"sic_description":null,"exchange":"Nasdaq","state_of_incorporation":null,"fiscal_year_end":null,"first_filing_date":"2026-05-08","last_filing_date":"2026-05-12","url":"/sec/cik-0001604464","insider_summary":{"total_transactions":0,"unique_insiders":0,"latest_transaction":null},"recent_filings":[{"accession_number":"0001193125-26-219420","form_type":"8-K","form_type_family":"current","doc_date":"2026-05-12","title":"8-K — Atara Biotherapeutics, Inc. — 2026-05-12","url_slug":"/sec/cik-0001604464/8-k/0001193125-26-219420","edgar_url":"https://www.sec.gov/Archives/edgar/data/1604464/0001193125-26-219420-index.html"},{"accession_number":"0001193125-26-219518","form_type":"424B5","form_type_family":"registration","doc_date":"2026-05-12","title":"424B5 — Atara Biotherapeutics, Inc. — 2026-05-12","url_slug":"/sec/cik-0001604464/424b5/0001193125-26-219518","edgar_url":"https://www.sec.gov/Archives/edgar/data/1604464/0001193125-26-219518-index.html"},{"accession_number":"0001193125-26-219482","form_type":"10-Q","form_type_family":"quarterly","doc_date":"2026-05-12","title":"10-Q — Atara Biotherapeutics, Inc. — 2026-05-12","url_slug":"/sec/cik-0001604464/10-q/0001193125-26-219482","edgar_url":"https://www.sec.gov/Archives/edgar/data/1604464/0001193125-26-219482-index.html"}],"related_endpoints":{"profile":"/sec/ATRA/profile","timeline":"/sec/ATRA/timeline","peers":"/sec/ATRA/peers","insider_pulse":"/sec/ATRA/insider-pulse","insider_summary":"/sec/ATRA/insider-summary","insider_transactions":"/sec/ATRA/insider-transactions","form144":"/sec/ATRA/form144","holdings_as_filer":"/sec/ATRA/holdings","financial_facts":"/sec/ATRA/financial-facts","derivatives":"/sec/ATRA/derivatives","officers":"/sec/ATRA/officers","insider_network":"/sec/ATRA/insider-network","risk_flags":"/sec/ATRA/risk-flags","filings":"/sec/ATRA/filings","cross_topic_dossier":"/api/v1/dossier?ticker=ATRA"}}